PubMed چکیده/رکورد

Understanding and Leveraging Implementation Science Within a Clinical Informatics Framework for Allergy/Immunology.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

The integration of research discoveries into routine clinical care is often slow and resource-intensive, particularly in allergy and immunology, where advances in biologics, immunotherapy, precision diagnostics, and guideline-driven management continue to evolve rapidly. Implementation science provides a structured approach to understand and address the gaps between research discovery and real-world patient care. In asthma, food allergy, atopic dermatitis, drug allergy, and primary immune disorders, variation in clinician knowledge, health system infrastructure, reimbursement models, patient demographics, and staffing patterns contribute to inconsistent uptake of evidence-based interventions. Implementation science offers tools to systematically evaluate these contextual factors and develop strategies that improve adoption, fidelity, sustainability, and equity in allergic and immunologic care. By offering theory-informed frameworks to design, adapt, and evaluate interventions across diverse clinical settings, implementation science advances the study of evidence-to-practice care gaps in allergy and immunology. When applied thoughtfully, these methods enhance implementation of specialty guidelines, practice parameters, and emerging therapies, while addressing multilevel determinants of care delivery. With the rapidly growing application of precision medicine and augmented intelligence to allergy and immunology practice, the study of how to best apply technological and research discovery to clinical practice will be needed to promote equitable uptake of evidence-based care.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Allergic diseasesArtificial intelligenceAsthmaDisseminationEvidence-based practiceFood allergyHealth equityImmunologyImplementation scienceInformatics
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

[THE TRADITIONAL AND COMPLEMENTARY MEDICINE IN THE PUBLIC HEALTH SYSTEM OF THE RUSSIAN FEDERATION: ANALYSIS OF EVIDENCE BASE AND LEGAL ASPECTS OF INTEGRATION].

The article considers placement of methods of traditional and complementary medicine in the public health system of the Russian Federation, focusing on prevention and management of chronic non-communicable diseases. The analysis of the evidence base on key methods of traditional and complementary medicine (acupuncture, phytotherapy, homeopathy, manual therapy, osteopathy) was carried out, including differentiated estimate of level of e…

PubMed2026

[Chinese expert consensus on the clinical application of lung biopsy in interstitial lung disease].

Interstitial lung disease (ILD) comprises a highly heterogeneous group of pulmonary disorders, whose diagnosis often requires the integration of clinical, radiologic, and pathologic evidence. Lung biopsy is a key method for obtaining a histopathologic diagnosis, but unified standards are lacking for determining indications, selecting biopsy techniques, managing patients perioperatively, and integrating pathologic and clinical informati…

PubMed2026

Targeted US Screening in High-Risk Newborns and Infants: Indications, Techniques, and Disease Findings.

Newborns and infants with certain perinatal exposures, congenital conditions, and genetic syndromes are at increased risk for clinically significant diseases and may benefit from early detection. In these children, imaging serves as a targeted screening tool to identify actionable abnormalities during a window in which intervention may reduce morbidity and long-term sequelae. The authors summarize evidence-based US screening strategies…

PubMed2026

The Promises and Perils of Clinical Decision Support Artificial Intelligence.

Evidence-based clinical decision support artificial intelligence (AI) is rapidly expanding, but its safe and effective use depends on rigorous validation, trustworthy evidence sources and careful integration into clinical workflows. Current available systems show strong potential to improve diagnostic accuracy, reduce clinician workload and possibly benefit patient care, but challenges remain before its real-world adoption. We must be …